Which MS treatment works best for patients over 50? new study aims to find out
NCT ID NCT07313462
First seen Jan 11, 2026 · Last updated Apr 28, 2026 · Updated 15 times
Summary
This study looks at 830 people with relapsing-remitting multiple sclerosis (MS) that started after age 50. Researchers compare two treatment strategies: starting with a moderate medication and switching if needed, versus starting with a stronger medication right away. The goal is to see which approach better prevents relapses and to identify factors linked to side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS (MS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre d'Investigation Clinique - CHU de Strasbourg - France
RECRUITINGStrasbourg, 67091, France
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.